125 related articles for article (PubMed ID: 24253156)
1. Reply to letter: "Clinical significance of the mesorectal extension as the prognostic predictor in rectal cancer".
Shirouzu K
Ann Surg; 2014 Mar; 259(3):e41. PubMed ID: 24253156
[No Abstract] [Full Text] [Related]
2. Clinical significance of the mesorectal extension as the prognostic predictor in rectal cancer.
Kobayashi T; Teruya M
Ann Surg; 2014 Mar; 259(3):e40. PubMed ID: 24263307
[No Abstract] [Full Text] [Related]
3. Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study.
Shirouzu K; Akagi Y; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
Ann Surg; 2011 Apr; 253(4):704-10. PubMed ID: 21475010
[TBL] [Abstract][Full Text] [Related]
4. Recurrence after total mesorectal excision.
Bokey EL; Chapuis PH; Dent OF
Dis Colon Rectum; 2005 Jun; 48(6):1323; author reply 1323. PubMed ID: 15906122
[No Abstract] [Full Text] [Related]
5. Population based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer.
Påhlman L
Tech Coloproctol; 2003 Jul; 7(2):120-121. PubMed ID: 14619871
[No Abstract] [Full Text] [Related]
6. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer.
Shin R; Jeong SY; Yoo HY; Park KJ; Heo SC; Kang GH; Kim WH; Park JG
Dis Colon Rectum; 2012 Dec; 55(12):1220-8. PubMed ID: 23135579
[TBL] [Abstract][Full Text] [Related]
7. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients.
Ramesh H; Bedi MS; Sikora SS
Ann Surg; 2006 Nov; 244(5):835-6; author reply 836. PubMed ID: 17060781
[No Abstract] [Full Text] [Related]
8. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer.
Cecil TD; Sexton R; Moran BJ; Heald RJ
Dis Colon Rectum; 2004 Jul; 47(7):1145-9; discussion 1149-50. PubMed ID: 15164243
[TBL] [Abstract][Full Text] [Related]
9. Anus-preserving operation for low rectal and anal canal cancers.
Shafik A
Tech Coloproctol; 2004 Mar; 8(1):56; author reply 56. PubMed ID: 15069934
[No Abstract] [Full Text] [Related]
10. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer.
Leite JS; Martins SC; Oliveira J; Cunha MF; Castro-Sousa F
Colorectal Dis; 2011 Apr; 13(4):381-6. PubMed ID: 20002696
[TBL] [Abstract][Full Text] [Related]
11. Local staging of rectal cancer with MRI using a phased array body coil.
Laghi A; Ferri M; Catalano C; Baeli I; Iannaccone R; Iafrate F; Ziparo V; Passariello R
Abdom Imaging; 2002; 27(4):425-31. PubMed ID: 12066241
[No Abstract] [Full Text] [Related]
12. A letter in response to rectal cancer: involved CRM - a root cause analysis.
Clements D; Carr ND; Beynon J
Colorectal Dis; 2010 Jan; 12(1):75; author reply 75-6. PubMed ID: 19769629
[No Abstract] [Full Text] [Related]
13. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
14. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
Wiig JN; Larsen SG; Dueland S; Giercksky KE
Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
[TBL] [Abstract][Full Text] [Related]
15. Role of local excision in the management of rectal cancer: what does the future hold?
Cataldo PA
Tech Coloproctol; 2016 Nov; 20(11):731-734. PubMed ID: 27766435
[No Abstract] [Full Text] [Related]
16. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.
Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J
Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035
[TBL] [Abstract][Full Text] [Related]
17. Pathological evidence in support of total mesorectal excision in the management of rectal cancer.
Kiss L; Kiss R; Porr PJ; Nica C; Nica C; Bardac O; Tănăsescu C; Bărbulescu B; Bundache M; Ilie S; Maniu D; Zaharie SI; Hulpuş R
Chirurgia (Bucur); 2011; 106(3):347-52. PubMed ID: 21853743
[TBL] [Abstract][Full Text] [Related]
18. Histopathology: improving outcomes in bowel cancer.
Palmer TG; West NP
Br J Hosp Med (Lond); 2015 May; 76(5):C69-73. PubMed ID: 25959952
[No Abstract] [Full Text] [Related]
19. Lymph node status does not predict local recurrence in the total mesorectal excision era.
Chand M; Moran BJ; Jones RG; Heald RJ; Brown G
Dis Colon Rectum; 2014 Jan; 57(1):127-9. PubMed ID: 24316956
[No Abstract] [Full Text] [Related]
20. Function vs fate?
Winslet M
Colorectal Dis; 2008 Jan; 10(1):2. PubMed ID: 18078458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
